YL-1-9
YL-1-9 is an inhibitor of the degradation of p53 by MDM2 through strong binding to the key hydrophobic pockets of MDM2. YL-1-9 induces cell cycle arrest and apoptosis in breast cancer cells[1].
Product Specifications
CAS Number
[3064304-12-4]
UNSPSC
12352005
Target
Apoptosis; CDK; MDM-2/p53
Related Pathways
Apoptosis; Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=C(NC1=CC(C(F)(F)F)=C(CN2CCC(C)CC2)C=C1)C3=CC(OCO4)=C4C=C3
Molecular Formula
C22H23F3N2O3
Molecular Weight
420.42
References & Citations
[1]Chongyun Zhou, et al. The novel Piperine derivative YL-1-9 exhibits anti-breast Cancer effects by inducing apoptosis via the p53/p21 pathway. Bioorg Med Chem Lett. 2025 Aug 1:123:130231.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15150193 1 Vial
Lentiviral human DAB1 shRNA (UAS) - Lentiviral human DAB1 shRNA (UAS, RFP) plasmid
Ask
View Details 034498-PE 200 µL
DCC, ID (DCC, IGDCC1, Netrin receptor DCC, Colorectal cancer suppressor, Immunoglobulin superfamily DCC subclass member 1, Tumor suppressor protein DCC) (PE) discontinued
Ask
View Details